ClinicalTrials.gg
CompletedNCT07874958Updated Oct 15, 2026

"AFRONTA Emotional Care" Intervention for Family Caregivers of Children With Cancer.

An interventional study of AFRONTA Emotional Care in Caregiver Burden, Child and Cancer, sponsored by Universidad de Guanajuato. Completed at 1 site in Mexico. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Universidad de Guanajuato · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jun 2025, registered Oct 2026).
Updated Oct 15, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The objective of the protocol is to evaluate the acceptability and feasibility of "AFRONTA Emotional Care" to reduce caregiver burden in family caregivers of children with cancer at a children's cancer foundation in Pachuca, Hidalgo, Mexico. The main questions to be answered are:

  • What is the acceptability and feasibility of "AFRONTA Emotional Care"?
  • Does the AFRONTA Emotional Care intervention reduce caregiver burden in family caregivers of children with cancer?

The researchers will

  • Implement a series of therapeutic sessions based on a dialogue circle where
  • They will guide specific objectives related to caregiver burden characteristics
  • They will administer a questionnaire before and after the sessions to evaluate the results The participants will
  • Sign informed consent
  • Attend the dialogue circle sessions
  • Develop exercise-based activities that promote active listening, respect, and empathy.
  • Wait your turn to speak and speak up (converse)
  • Promote the collective development of ideas and the resolution of care-related conflicts.
Read the detailed description

The intervention "AFRONTA Emotional Care to Reduce Caregiver Overload" proposed to reduce the caregiver overload of a child with cancer through the strengthening of emotional coping strategies based on the management of anxiety, stress and depression, for which components that influence these same variables were considered from intervention studies and showing a relationship with the NIC taxonomy of nursing science. In this sense, the intervention was aimed at identifying emotional coping strategies, encouraging their use and providing new ways of coping which contribute to their well-being and stress management, which represents the main stimulus, according to the Middle Range Coping Theory. The scope of the intervention was based on providing tools for relaxation techniques, emotional support and, therefore, that caregivers have the fundamental bases for the management of anxiety, depression and stress.

On the other hand, each session was made up of a maximum of 10 people who received an intervention of 3 sessions of dialogue circles for the management of emotions supported by the technique of dialogue circles that aims to improve emotional coping and reduce caregiver overload from the creation of safe spaces (circles) that allow people to be protagonists of the situation, express with complete confidence problems, difficulties and feelings that are inherent to their role as caregivers, in addition to the expression of emotions and experiences that in a guided way they can share from an environment of confidentiality and mutual respect.

The caregivers' time is essential, therefore, the recommendation of the author like Tinoco who has had experiences in the application of dialogue circles mentions first hand that it is important not to exceed more than 3 circles because it is an unexplored population, so it can be counterproductive in the acceptability and viability of the study, since if more than 3 circles are proposed at the beginning, people may possibly reject the invitation for being too long. In addition to this, the intervention studies mentioned above also recommend a reduced number of sessions in this specific population.

Furthermore, agreements will be incorporated into the activities that allow for the appropriate use of voice, participation, and topics to be discussed. In the first circle, the facilitator will explain the methodology and dynamics of the circles, and then each participant will introduce themselves to the rest, one by one. The use of the article will be explained. This is a material object that indicates whose turn it is to speak at that moment and that the others should pay attention and remain silent. The object will be passed around the circle in the hands of the participants, giving each the opportunity to share their thoughts and feelings if they wish.

02

Conditions studied

  • Caregiver Burden
  • Child
  • Cancer

Keywords

  • Caregiver burden
  • cancer child
03

In context

Caregiver Burden

439 studies on the registry are indexed under Caregiver Burden; 154 are open to participants now.

This study's enrollment of 14 is below the median of 75 across 346 interventional studies indexed under Caregiver Burden.

Browse Caregiver Burden studies →

Lead sponsor

Universidad de Guanajuato is the lead sponsor of 37 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • parent of a child with cancer
  • primary caregiver
  • experiencing a mild or excessive burden

Exclusion criteria

Exclusion Criteria:

  • psychological therapy, medical or psychiatric treatment for emotional problems
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Caregivers of children with cancer

    An intervention for caregivers consisting of five group sessions addressing the care involved in looking after a child with cancer, while emphasizing the importance of physical and emotional self-care in each session.

    Other: AFRONTA Emotional Care

Interventions

  • OtherAFRONTA Emotional Care

    Group intervention in which caregivers express their feelings through the dialogue circle tool.

    Also known as: AFRONTA, Emotional Care

06

What researchers measure

Primary outcomes

  1. Acceptability

    It is assessed using the "Intervention Acceptability" questionnaire, which consists of 37 items organized into 6 sections: Section 1. Open-ended questions: positive aspects of the intervention and areas for improvement; Section 2. Intervention content; Section 3. Delivery method; Section 4. Benefits of the intervention; Section 5. Drawbacks of participating in the study; Part 6. Overall acceptability. The questions in Parts 2 through 6 use a Likert scale ranging from 1 to 5; higher scores indicate a higher level of acceptance of the intervention and its components. In addition, the study will be evaluated based on the enrollment rate (the number of people who agree to participate divided by the total number of people who met the inclusion criteria, multiplied by 100) and the dropout rate (the total number of people who drop out of the study divided by the total number who agreed to participate, multiplied by 100).

    Time frame: 3 months

  2. Feasibility

    Feasibility is assessed descriptively based on five indicators: material resources, contextual characteristics, human resources, the interventionist's training, and implementation of the intervention (aspects of clarity, comprehensiveness, and logical sequence of the information provided to participants; the ease with which the intervention activities were carried out as directed; the time it took to deliver the various components of the intervention; relevance of the components; difficulties in implementing the recommendations)

    Time frame: 3 months

Secondary outcomes

  1. Caregiver burden

    Zarit Caregiver Burden Scale for Children with Chronic Illnesses: validated in Mexico by Montero, Jurado, Valencia, Méndez, and Mora in 2014, with a Cronbach's alpha of 0.84, criterion validity r = 0.46, and construct validity r = 0.36. It consists of 12 Likert-scale items (1=never, 2=almost never, 3=sometimes, 4=often, and 5=always). The cut-off scores are: 12 to 22 indicates no burden, 23 to 29 indicates mild burden, and 30 to 60 indicates excessive burden. It also consists of three dimensions or factors: the impact of care, interpersonal relationships, and self-efficacy expectations. The higher the score, the greater the burnout.

    Time frame: 3 months

07

Study locations

1 site
  • Foundation for children with cancer
    Pachuca, Pachuca 42083, Mexico
08

References and documents

Individual participant data

Plan to share: No — The data will not be shared with other researchers.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Oct 2025, 4 months.

Of 253 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 32. This study's 4 months is below that.

Counting every sponsor, half of 261 studies reached it within 16 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2026
First posted
Oct 15, 2026
StartActual
Jun 1, 2025
Primary completionActual
Oct 20, 2025
CompletionActual
Oct 30, 2025
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07874958
Lead sponsor
Universidad de Guanajuato
Collaborators
Universidad Autónoma del Estado de Hidalgo
Responsible party
José Manuel Herrera Paredes (Doctor of Nursing Sciences, Universidad de Guanajuato) — Principal investigator
First posted
Oct 15, 2026
Start date
Jun 1, 2025
Primary completion
Oct 20, 2025
Completion
Oct 30, 2025
Last update
Oct 15, 2026

Study contacts

Aldo Pelcastre Neri, Doctor in Nursing Science
principal investigator · Universidad Autónoma del Estado de Hidalgo

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion